Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

Fig. 2

Cumulative probability of persistence with initial statin therapy during the 5-year follow-up period. Probability in the whole sample (graph a), patients without previous cardiovascular events (graph b) or with previous cardiovascular events (graph c). HR: Hazard Ratio with 95% confidence interval adjusted by age, sex, number of comorbidities, Charlson index, resource utilization band (RUB), proportion of subjects reaching their LDL-cholesterol goal at the start of therapy and statin type

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X